IntelGenx Technologies (IGXT)
(Delayed Data from OTC)
$0.17 USD
0.00 (0.00%)
Updated May 16, 2024 03:57 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
IGXT 0.17 0.00(0.00%)
Will IGXT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IGXT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for IGXT
IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process
IntelGenx Obtains Preliminary Efficacy Results for the `BUENA? Montelukast VersaFilm? Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer?s Disease
IntelGenx Announces Initiation of the Sale and Investment Solicitation Process
IntelGenx Initiates Strategic Sale Process
IntelGenx announces initiation of sale and investment solicitation process